Move Over SpaceX: These 2 Space Stocks Are Nipping at Its Heels

Article spotlights post–SpaceX IPO competition in satellite services and launches, highlighting Rocket Lab’s Electron (91 launches; 262+ satellites deployed) and expected Neutron first flights by year-end, plus Rocket Lab’s pending $8B acquisition of Iridium to expand monetization. It also frames AST SpaceMobile as a competitive threat to Starlink, citing Verizon and AT&T developmental partnerships, nearly $4.2B Starlink revenue last year, and analyst expectations for AST stop-line growth of 140% this year and 340% next year, targeting profitability by 2028—though with “volatility” risk.

Analysis

The market is still pricing “space” as a TAM story, but the investable edge is in bottlenecks: launch cadence, satellite manufacturing, and carrier distribution. That favors RKLB over the more narrative-driven names because it can monetize multiple layers of the stack; if Neutron slips, however, the stock likely de-rates fast because the market is paying for a near-term operating inflection, not just long-dated optionality.

ASTS is the cleaner pure-play on satellite-to-device broadband, but the consensus is probably too linear on adoption. The choke point is not demand, it is capital intensity and execution: every quarter of delay raises dilution risk and pushes out EBITDA break-even, while carrier partnerships reduce customer acquisition friction but do not eliminate launch and spectrum integration risk. VZ and TMUS are not earnings shorts here; their involvement mainly accelerates product credibility and shifts bargaining power away from a single-anchor distribution model.

IRDM matters as a cash-flow bridge if the acquisition closes, because it can make RKLB less of a one-product story and more of a recurring-revenue platform. The contrarian view is that ASTS may be overowned as a “next Starlink” trade, while RKLB may be underappreciated as the more diversified asset with a nearer catalyst path. Over the next 1-3 months, the tape should be driven by milestone risk, not addressable-market slides; over 6-18 months, the winners will be the names that can show repeatable launches or contracts without repeated equity issuance.

Key Decisions for Investors

• Long RKLB vs short ASTS as a relative-value pair into year-end catalyst risk; thesis is higher execution visibility and better mix diversification at RKLB. Cut the pair if RKLB misses Neutron timing or if ASTS posts a material launch/customer milestone.
• Avoid chasing ASTS strength until there is evidence of satellite deployment consistency and lower dilution intensity; use pullbacks only after financing risk is clearer. The upside is real, but the path likely remains equity-funded for longer than bulls assume.
• Set a watch item on IRDM/RKLB deal spread and financing terms; if the merger spread remains wide after regulatory milestones, a deal-arb long IRDM / short RKLB could become attractive, but only if closing risk is quantifiable.
• Treat T, TMUS, and VZ as beneficiaries of optionality rather than shorts; no clean directional trade unless carrier attach rates or roaming economics show up as a measurable ARPU/margin headwind in upcoming guidance.